Revenue from Operations stood at Rs. 2,607 crore, 25% YoY growth. Domestic revenue at Rs. 2,400 crore, 20% YoY growth and export revenue at Rs. 207 crore, 118% YoY growth
The registered capital of the newly founded company is € 50 million
Inducts advanced AI-Powered 24x7 remote patient monitoring system
India’s First Integrated Ayush Wellness Centre to come up in Guwahati, foundation stone laid
Shivalik Rasayan Limited have successfully submitted USMDF for API " Palbociclib " to USFDA
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
Ribo's cutting edge RIBO-GalSTAR platform enables the development of RNAi therapeutics targeting disease-causing genes specifically in hepatocytes
Marks remarkable acceleration in innovation using AI technology
US FDA approval based on NEURO-TTRansform Phase III results
His resignation would be effective from March 18, 2024
Subscribe To Our Newsletter & Stay Updated
